Your browser doesn't support javascript.
loading
Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008.
Popov, Alexander; Henze, Guenter; Roumiantseva, Julia; Budanov, Oleg; Verzhbitskaya, Tatiana; Boyakova, Elena; Tsaur, Grigory; Fadeeva, Maria; Lagoyko, Svetlana; Zharikova, Liudmila; Miakova, Natalia; Litvinov, Dmitry; Khlebnikova, Olga; Streneva, Olga; Ponomareva, Natalia; Novichkova, Galina; Fechina, Larisa; Karachunskiy, Alexander.
Afiliação
  • Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation. Electronic address: uralcytometry@gmail.com.
  • Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Boyakova E; Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation.
  • Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Fadeeva M; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation.
  • Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Leuk Res ; 125: 106998, 2023 02.
Article em En | MEDLINE | ID: mdl-36566537
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leuk Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leuk Res Ano de publicação: 2023 Tipo de documento: Article